Latest Announcements

Investor Announcement

Prana receives Orphan Designation for PBT434 for treatment of MSA

Prana receives first orphan drug designation from the FDA for the treatment of Multiple System Atrophy

Email Newsletter

Receive news from Prana Biotechnology by entering your details below and clicking "Subscribe"